Arisgen

Arisgen has a unique formulation technology that will enable peptide drugs such as insulin currently only delivered by injection to be given orally.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Geneva, Switzerland
  • Currency CHF
  • Founded 2008
  • Employees 6
  • Website arisgen.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free